SCHEMBL17356807

SCHEMBL17356807

COc1cccc(C)c1C1CCCC(c2c(C)cccc2OC)C1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.40
ABCB1 P08183 1/20 0.40
HSD11B1 P28845 1/20 0.38
DRD2 P14416 3/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
ADRA1A P35348 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17356787 0.91 HTR2C (0.40) HSD11B1MAPTHPGDCA1CA2
SCHEMBL17356785 0.91 HTR1A (0.38) HTR1AABCB1DRD2HCRTR1HCRTR2
SCHEMBL17356791 0.85 ABCB1 (0.42) HTR1AABCB1HSD11B1DRD2TAS1R3
SCHEMBL17356793 0.77 ABCB1 (0.43) HTR1AABCB1HSD11B1DRD2TAS1R3
SCHEMBL16955777 0.77 ABCB1 (0.53) HTR1AABCB1DRD2HCRTR1HCRTR2
SCHEMBL17356788 0.74 HTR2C (0.50) HSD11B1DRD2CA1CA2
SCHEMBL22877153 0.72 ADRA1A (0.50) HTR1AABCB1HSD11B1DRD2ADRA1A
SCHEMBL17356805 0.72 PNMT (0.43) TAS1R3TAS1R1TAS1R2HCRTR1
SCHEMBL20052962 0.70 ALDH1A1 (0.43) HTR1AABCB1ADRA1AKDM4EALDH1A1
SCHEMBL2960964 0.70 FFAR1 (0.43) HCRTR1HCRTR2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170313792-A1 METHOD FOR PRODUCING POLAR GROUP-CONTAINING OLEFIN POLYMER THE UNIVERSITY OF TOKYO (JP) 2017-11-02 US disclosed
US-9499644-B2 Production method of polar group-containing olefin polymers SHOWA DENKO K.K. (JP) 2016-11-22 US disclosed
US-20150368376-A1 PRODUCTION METHOD OF POLAR GROUP-CONTAINING OLEFIN POLYMERS SHOWA DENKO K.K. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368376-A1 PRODUCTION METHOD OF POLAR GROUP-CONTAINING OLEFIN POLYMERS OR10J3, OPRM1, ORC3 HTR1A 3188/4885ABCB1 3562/4885HSD11B1 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.